MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Perception of the Deep Brain Stimulation Therapeutic Window: An Anatomically Informed Survey

L. Gozman, J. Wong, L. Fanty (Gainesville, USA)

Meeting: 2025 International Congress

Keywords: Deep brain stimulation (DBS)

Category: Technology

Objective: To assess DBS practitioners’ perceptions of the therapeutic window at the level of electrode contacts.

Background: Deep brain stimulation (DBS) is an effective treatment for movement disorders, but requires manual adjustment of multiple device parameters that influence therapeutic outcomes. Consequently, the perception of the size of the therapeutic window (TW) is variable among DBS centers.  This study aims to evaluate DBS practitioners’ perceptions of the therapeutic window at the level of individual electrode contacts, accounting for the spatial influence on its delineation.

Method: Clinical DBS programmers at the University of Florida were surveyed via REDCap on their perception of the therapeutic window with respect to amplitude, pulse width and frequency. Scores were aggregated and analyzed using bootstrap resampling with 1000 iterations to estimate the mean and 95% confidence interval (CI) of the therapeutic window based on the survey responses.

Results: The therapeutic window increased as contacts moved dosrally for all targets, with GPi demonstrating the highest thresholds (Figure 1).  The mean (95% CI) amplitude for contacts 0, 1, 2 and 3 in the GPi were 2.79 (2.50–3.04), 3.38 (3.13–3.63), 4.07 (3.79–4.36), and 4.25 (3.97–4.51) respectively. For the STN, the mean (95% CI) amplitude for contacts 0, 1, 2 and 3 were 2.06 (1.85–2.27), 2.42 (2.20–2.65), 2.62 (2.40–2.83), and 2.67 (2.47–2.86) respectively. In the VIM, the mean (95% CI) amplitude for contacts 0, 1, 2 and 3 were 2.36 (2.12–2.57), 2.98 (2.75–3.22), 3.23 (3.00–3.48), and 3.41 (3.19–3.63) respectively.

Conclusion: Practitioner perceptions of the DBS therapeutic window vary by target and contact level, supporting the anatomic considerations on therapeutic window estimation. This survey represents the first step towards establishing a universal standard for monopolar review and therapeutic window interpretation to facilitate improving DBS outcomes.

Figure 1.

Figure 1.

To cite this abstract in AMA style:

L. Gozman, J. Wong, L. Fanty. Perception of the Deep Brain Stimulation Therapeutic Window: An Anatomically Informed Survey [abstract]. Mov Disord. 2025; 40 (suppl 1). https://www.mdsabstracts.org/abstract/perception-of-the-deep-brain-stimulation-therapeutic-window-an-anatomically-informed-survey/. Accessed October 5, 2025.
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2025 International Congress

MDS Abstracts - https://www.mdsabstracts.org/abstract/perception-of-the-deep-brain-stimulation-therapeutic-window-an-anatomically-informed-survey/

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • AI-Powered Detection of Freezing of Gait Using Wearable Sensor Data in Patients with Parkinson’s Disease
  • Effect of Ketone Ester Supplementation on Motor and Non-Motor symptoms in Parkinson's Disease
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Life expectancy with and without Parkinson’s disease in the general population
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Insulin dependent diabetes and hand tremor
  • Improvement in hand tremor following carpal tunnel release surgery
  • Impact of expiratory muscle strength training (EMST) on phonatory performance in Parkinson's patients
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley